Summary of findings table ‐ Cannabis vs placebo
Health‐related quality of life. Mean change from baseline · health problem or population
1 finding from 1 review
- Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis 2022 · Cochrane Headline outcomes onlyno estimate extracted8 studies · 1942 participantsLow